4.13

0.48% -0.02

After Hours: 4.13

Petmed Express, Inc. (PETS)

Overview News Price History Option Chain Why PETS Down? Discussions Forecast Stock Split Dividend History

Petmed Express, Inc. stock is currently priced at $4.13, with a 24-hour trading volume of 252.78K. It has seen a -0.48% decreased in the last 24 hours and a -12.13% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $4.12 pivot point. If it approaches the $4.20 resistance level, significant changes may occur.

Previous Close:

$4.15

Open:

$4.14

24h Volume:

252.78K

Market Cap:

$87.34M

Revenue:

$270.52M

Net Income/Loss:

$-6.08M

P/E Ratio:

-25.67

EPS:

-0.1609

Net Cash Flow:

$17.42M

1W Performance:

-2.13%

1M Performance:

-12.13%

6M Performance:

-56.02%

1Y Performance:

-73.09%

1D Range:

$4.085

$4.19

52W Range:

$4.01

$16.18

Petmed Express, Inc. Stock (PETS) Company Profile

Name

Petmed Express, Inc.

Sector

Healthcare (1198)

Industry

Pharmaceutical Retailers (10)

Phone

561-526-4444

Address

420 South Congress Avenue, Delray Beach

Employee

187

Twitter

@1800petmeds

Next Earnings Date

2024-05-20

Latest SEC Filings

PETS's Discussions on Twitter

Petmed Express, Inc. Stock (PETS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-25-23	Initiated	Lake Street	Buy
Jan-20-22	Upgrade	Sidoti	Neutral → Buy
Nov-18-21	Initiated	Morgan Stanley	Underweight
Oct-01-21	Initiated	Jefferies	Hold
Aug-05-21	Resumed	Credit Suisse	Underperform
Jun-03-21	Downgrade	Sidoti	Buy → Neutral
Mar-05-21	Upgrade	Sidoti	Neutral → Buy
Jan-27-21	Downgrade	Sidoti	Buy → Neutral
Aug-19-20	Upgrade	Sidoti	Neutral → Buy
Apr-09-20	Downgrade	Sidoti	Buy → Neutral
Mar-12-20	Upgrade	Sidoti	Neutral → Buy
Feb-24-20	Downgrade	Sidoti	Buy → Neutral
Aug-16-19	Downgrade	Craig Hallum	Buy → Hold
Jun-15-18	Initiated	CL King	Neutral
Aug-24-17	Upgrade	Sidoti	Neutral → Buy
Jul-24-17	Upgrade	Northcoast	Neutral → Buy
May-09-16	Upgrade	Craig Hallum	Sell → Hold
Feb-04-16	Initiated	Credit Suisse	Underperform
Jul-19-10	Downgrade	CL King	Strong Buy → Accumulate
Jul-19-10	Reiterated	JMP Securities	Mkt Outperform
May-25-10	Downgrade	Wedbush	Neutral → Underperform
May-06-10	Reiterated	Wedbush	Neutral
Mar-23-10	Downgrade	Janney Mntgmy Scott	Buy → Neutral
Mar-18-10	Downgrade	Piper Jaffray	Overweight → Neutral
Feb-16-10	Reiterated	CL King	Strong Buy
Jul-21-09	Upgrade	Piper Jaffray	Neutral → Overweight
Jan-07-09	Initiated	CL King	Strong Buy

View All

Petmed Express, Inc. Stock (PETS) Latest News

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

GlobeNewswire Inc.

PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters

GlobeNewswire Inc.

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

GlobeNewswire Inc.

Petmed Express, Inc. Stock (PETS) Financials Data

Petmed Express, Inc. (PETS) Revenue 2024

PETS reported a revenue (TTM) of $270.52 million for the quarter ending September 30, 2023, a +3.13% rise year-over-year.

Petmed Express, Inc. (PETS) Net Income 2024

PETS net income (TTM) was -$6.08 million for the quarter ending September 30, 2023, a -138.77% decrease year-over-year.

Petmed Express, Inc. (PETS) Cash Flow 2024

PETS recorded a free cash flow (TTM) of $17.42 million for the quarter ending September 30, 2023, a -10.28% decrease year-over-year.

Petmed Express, Inc. (PETS) Earnings per Share 2024

PETS earnings per share (TTM) was -$0.2944 for the quarter ending September 30, 2023, a -137.74% decline year-over-year.

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.